Combined treatment of endometriosis in infertile patients with gonadotropin-releasing hormone agonist or dienogest

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• An evidence-based evaluation of endometriosis-associated infertility via openalex
• Decorin induced by progesterone plays a crucial role in suppressing endometriosis via openalex
• Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis via openalex
• Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
• Endometriosis: alternative methods of medical treatment via openalex
• Management of infertility in women with endometriosis. via openalex
• Medical management of endometriosis and infertility via openalex
• Medical Treatments for Endometriosis-Associated Pelvic Pain via openalex
• [MINIMAL AND MILD ENDOMETRIOSIS: WHICH IMPACT ON FERTILITY?]. via openalex
• Novel Medical Treatment Modalities of Endometriosis via openalex
• Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
• Urinary incontinence and bladder endometriosis: conservative management via openalex
• Use of dienogest over 53 weeks for the treatment of endometriosis via openalex

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00